Cytek Biosciences (CTKB) Change in Acquisitions & Divestments (2023 - 2026)

Cytek Biosciences' Change in Acquisitions & Divestments history runs 4 years deep, the most recent figure standing at $70.7 million for Q1 2026.

• Quarterly Change in Acquisitions & Divestments changed 0.4% year-over-year to $70.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $292.5 million (up 51.21% YoY) and the FY2025 annual result came in at $292.2 million, up 49.85% from the prior year.
• Change in Acquisitions & Divestments was $70.7 million for Q1 2026 at Cytek Biosciences, down from $76.1 million in the prior quarter.
• Across five years, Change in Acquisitions & Divestments topped out at $79.2 million in Q3 2025 and bottomed at $10.0 million in Q2 2023.
• A 4-year average of $57.5 million and a median of $67.2 million in 2023 frame the typical range for Change in Acquisitions & Divestments.
• Peak annual rise in Change in Acquisitions & Divestments reached 300.0% in 2024, while the deepest fall reached 44.12% in 2024.
• Cytek Biosciences' Change in Acquisitions & Divestments stood at $54.0 million in 2023, then decreased by 16.67% to $45.0 million in 2024, then jumped by 69.12% to $76.1 million in 2025, then retreated by 7.08% to $70.7 million in 2026.
• Business Quant data shows CTKB's Change in Acquisitions & Divestments at $70.7 million in Q1 2026, $76.1 million in Q4 2025, and $79.2 million in Q3 2025.